It is well known that osteoporosis is a significant chronic disease with the increase of the aging population. Here, we report that expression of G protein-coupled receptor 35 (GPR35) in bone marrow mesenchymal stem cells (BMSCs) is suppressed in diagnosed osteoporosis patients and osteoporotic mice. The expression of GPR35 on BMSCs is enhanced during osteogenic differentiation. GPR35 knockout suppresses the proliferation and osteogenesis of BMSCs and deteriorates bone mass in both sham-treated and ovariectomized mice. Moreover, GPR35 deficiency reduces β-catenin activity in BMSCs. In contrast, the overexpression of GPR35 contributes to these processes in BMSCs. Finally, using zaprinast, a synthetic GPR35 agonist, we show that zaprinast rescues OVX-induced bone loss and promotes bone generation in mice. Thus, GPR35 may as a new target and its agonist zaprinast may serve as a novel treatment for osteoporosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bbrc.2021.03.084 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Investigating the Role of TRPV4 and GPR35 Interaction in Endothelial Dysfunction in Aging Mice.
Aging Cell
January 2025
Wuxi School of Medicine, Jiangnan University, Wuxi, China.
Endothelial dysfunction, characterized by a decline in endothelial physiological functions, is a significant aspect of cardiovascular aging, contributing notably to arterial stiffness, atherosclerosis, and hypertension. Transient receptor potential channel V4 (TRPV4), a key member of Ca-permeable channels, plays a crucial role in maintaining vascular functions. However, the role and mechanisms of TRPV4 in aging-related endothelial dysfunction remain incompletely understood.
View Article and Find Full Text PDFBiased constitutive signaling of the G protein-coupled receptor GPR35 suppresses gut barrier permeability.
J Biol Chem
November 2024
Centre for Translational Pharmacology, School of Molecular Biosciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom. Electronic address:
Article Synopsis
- Constitutive activity of G protein-coupled receptors, like GPR35, plays a key role in maintaining the integrity of the epithelial barrier in the gut, which is crucial for preventing inflammatory diseases.
- Studies showed that certain inverse agonists could disrupt this barrier function in colonic organoids, suggesting the importance of GPR35's ongoing, or "constitutive," activation.
- The research found that the activity of GPR35 varies depending on the specific signaling pathways and levels of receptor expression, highlighting its complex role in cellular responses and potential therapeutic implications for inflammatory bowel conditions.
Phased chromosome-level genome provides insights into the molecular adaptation for migratory lifestyle and population diversity for Pacific saury, Cololabis saira.
Commun Biol
November 2024
Research Centre for Deep Sea and Polar Fisheries, and Key Laboratory of Mariculture, Ministry of Education, Ocean University of China, Qingdao, China.
The Pacific saury (Cololabis saira) is a pelagic fish commonly found in the North Pacific Ocean. Its population diversity and migratory lifestyle have long captured global attention. Despite the inherent complexity of the C.
View Article and Find Full Text PDFGenetic overlap between inflammatory bowel disease and iridocyclitis: insights from a genome-wide association study in a European population.
BMC Genom Data
October 2024
Formula-Pattern Research Center, Jiangxi University of Chinese Medicine, Nanchang, China.
Article Synopsis
- Inflammatory bowel disease (IBD) is linked with eye conditions like iridocyclitis (IC), potentially due to shared genetics, as indicated by increasing occurrences of both conditions.
- A comprehensive analysis using genetic data revealed positive correlations between IBD, ulcerative colitis (UC), and IC, particularly on chromosomes 1 and 6, but showed weaker connections for Crohn's disease (CD) and certain types of IC.
- The study identified specific genes, such as IL23R and GPR35, common to both conditions, highlighting a shared genetic foundation that may inform future treatment and prevention strategies for IBD and IC.
GPR35 agonists inhibit TRPA1-mediated colonic nociception through suppression of substance P release.
Pain
October 2024
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom.
The development of nonopioid analgesics for the treatment of abdominal pain is a pressing clinical problem. To address this, we examined the expression of Gi/o-coupled receptors, which typically inhibit nociceptor activation, in colonic sensory neurons. This led to the identification of the orphan receptor GPR35 as a visceral analgesic drug target because of its marked coexpression with transient receptor potential ankyrin 1 (TRPA1), a mediator of noxious mechanotransduction in the bowel.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!